Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells

The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors

(2017) Allan Lipton et al.   Journal of the National Comprehensive Cancer Network

Cancer treatment and survivorship statistics, 2016

(2016) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The hematopoietic stem cell niche in homeostasis and disease

(2015) L. M. Calvi et al.   BLOOD

Lung-Derived Factors Mediate Breast Cancer Cell Migration through CD44 Receptor-Ligand Interactions in a Novel Ex Vivo System for Analysis of Organ-Specific Soluble Proteins

(2015) Jenny E. Chu et al.   NEOPLASIA

Contributions of the Host Microenvironment to Cancer-Induced Bone Disease

(2014) Sam W.Z. Olechnowicz et al.   CANCER RESEARCH

Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth

(2014) Alexander Pietras et al.   Cell Stem Cell

Osteopontin Knockdown Inhibits av,�3Integrin-Induced Cell Migration and Invasion and Promotes Apoptosis of Breast Cancer Cells by Inducing Autophagy and Inactivating the PI3K/Akt/mTOR Pathway

(2014) Hao Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy

(2013) Seth A. Wander et al.   BREAST CANCER RESEARCH AND TREATMENT

Determining Mammosphere-Forming Potential: Application of the Limiting Dilution Analysis

(2012) Lauren M. Rota et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor

(2012) Patrizia Nanni et al.   PLoS One

Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells

(2011) Alysha K. Croker et al.   BREAST CANCER RESEARCH AND TREATMENT

Understanding the Dual Nature of CD44 in Breast Cancer Progression

(2011) J. M. V. Louderbough et al.   MOLECULAR CANCER RESEARCH

Advances in the biology of bone metastasis: How the skeleton affects tumor behavior

(2010) Julie A. Sterling et al.   BONE

Emerging roles for WNK kinases in cancer

(2010) Sónia Moniz et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Osteopontin: An Effector and an Effect of Tumor Metastasis

(2010) L. Shevde et al.   CURRENT MOLECULAR MEDICINE

The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization

(2010) J-P Lévesque et al.   LEUKEMIA

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

(2010) J. N. Andersen et al.   Science Translational Medicine

Examining the Metastatic Niche: Targeting the Microenvironment

(2010) Theresa Guise   SEMINARS IN ONCOLOGY

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

LINGO-1 Interacts with WNK1 to Regulate Nogo-induced Inhibition of Neurite Extension

(2009) Zhaohuan Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cancer stem cells: implications for the progression and treatment of metastatic disease

(2008) A.K Croker et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

(2008) Alysha K. Croker et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE